Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stromagen in metastatic breast cancer
NCT00003877Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Sep 1998
- Primary completion
- Feb 2000
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of remestemcel-L-rknd in breast cancer, sponsored by Roswell Park Comprehensive Cancer Center. Started Sep 1998; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003877.